Brand Post July 11, 2024 Metrea Announces Acquisition of French Air & Space Force Tanker Fleet WASHINGTON, July 11, 2024 /PRNewswire/ -- Today Metrea announced that it has completed the acquisition of the French Air and…
Brand Post July 11, 2024 GENESIS MAGMA MAKES GLOBAL DYNAMIC DEBUT AT GOODWOOD FESTIVAL OF SPEED, TAKING ONE STEP CLOSER TO PRODUCTION Magma vehicles to be shown in action for first time following high-performance program's official launch in MarchGV60 Magma Concept, G80…
Brand Post July 11, 2024 BIRKENSTOCK APPOINTS NEW MANAGING DIRECTOR FOR SOUTH-EAST ASIA AND DOWN UNDER: EVELYN CHUA TO ACCELERATE GROWTH AND TO DEEPEN ITS FOOTPRINT IN THE WHITE SPACE REGION LINZ, Germany, July 11, 2024 /PRNewswire/ -- BIRKENSTOCK has appointed Evelyn Chua as Managing Director for South-East Asia and Down…
Brand Post July 11, 2024 X-Silicon CEO and Chief Scientist featured on SBT C-Suite Spotlight SAN DIEGO, July 11, 2024 /PRNewswire/ -- X-Silicon CEO, Dan Nilsson and Atif Zafar, Chief Scientist are featured on SBT C-Suite…
Brand Post July 11, 2024 NFP Forms Partnership with Irish Racing Cyclist Kelly Murphy Murphy, who becomes just the second sportsperson in the UK and Ireland to partner with NFP, will benefit from NFP's…
Brand Post July 11, 2024 Open Payment Technologies Ltd Launches the Kuady Digital Wallet App to Revolutionize Financial Management Kuady now live in LatAm, with Africa and Europe to followLONDON, July 11, 2024 /PRNewswire/ -- Open Payment Technologies Ltd,…
Brand Post July 11, 2024 Over 30 vessels to be constructed by Hengli this year DALIAN, China, July 11, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: Hengli Heavy Industries plans to commence construction on over…
Brand Post July 11, 2024 Patent rights jointly owned by the National Cancer Center and the University of Pennsylvania, licensed to ARC Therapies, Inc. Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) TOKYO, July 11, 2024 /PRNewswire/ --…
Brand Post July 11, 2024 ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug’s First Clinical Trial Target as ‘Prostate Cancer Patients Resistant to Hormone Therapy’ IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024.Niclosamide-based…
Brand Post July 11, 2024 Official Swiss delegation experiences new frontiers in art tech at HKBU HONG KONG, July 11, 2024 /PRNewswire/ -- A senior Swiss delegation led by Mr Guy Parmelin, Swiss Federal Councillor and Head…
Brand Post July 11, 2024 Freedomverse and the Tourism Authority of Thailand Partner to Elevate Thailand Travel Experience with the Freedom World Mobile App 'Discover Thailand Community' To Build a Traveler Community for the New Generation BANGKOK, July 11, 2024 /PRNewswire/ -- Freedomverse, the…
Brand Post July 11, 2024 iQIYI Launches AI Chatbots for Popular Show Characters, Enhancing Interactive Content Experience BEIJING, July 11, 2024 /PRNewswire/ -- On July 9, iQIYI, a leading online entertainment service in China, announced the launch…